Schedule 13G ownership disclosure

Adamis Pharmaceuticals Corp

Security class unavailable · CUSIP: 00547W208

Event date: 2019-08-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001013594-19-000493
Form type
SC 13G
Filer
683 Capital Management, LLC
CIK
CIK 1404574
Filed
Aug 12, 2019
Reporting period
Aug 01, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub